EUVIMEDEUVIMED entdecken
Open Access

Enhanced IgG immune response to COVID ‐19 vaccination in patients with sickle cell disease

Hirotomo Nakahara iD, Narayanaiah Cheedarla, Hans P Verkerke, Suneethamma Cheedarla, Shang-Chuen Wu, Jeanne E Hendrickson iD, Andres Chang, Morgan L McLemore, Fuad El Rassi, John D Roback, Andrew S Neish, Ross M Fasano iD und 1 weitere

British Journal of Haematology · 2023

DOI: 10.1111/bjh.18899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Hirotomo Nakahara und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, Anemia, Sickle Cell. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with sickle cell disease (SCD) are considered to be immunocompromised, yet data on the antibody response to SARS‐CoV‐2 vaccination in SCD is limited. We investigated anti‐SARS‐CoV‐2 IgG titres and overall neutralizing activity in 201 adults with SCD and demographically matched non‐SCD controls. Unexpectedly, patients with SCD generate a more robust and durable COVID‐19 vaccine IgG response compared to matched controls, though the neutralizing activity remained similar across both cohorts. These findings suggest that patients with SCD achieve a similar antibody response following COVID‐19 vaccination compared to the general population, with implications for optimal vaccination strategies for patients with SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Anemia, Sickle CellAdultHumansCOVID-19 VaccinesSARS-CoV-2VaccinationImmunoglobulin GAntibodies, ViralImmunityAntibodies, Neutralizing

Stichwörter der Autor:innen

antibodieshaemoglobinopathiesimmunologysickle cell anaemiasickle cell diseasevaccines

Substanzen

COVID-19 VaccinesImmunoglobulin GAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Hirotomo Nakahara, Jeanne E Hendrickson, Ross M Fasano, Sean R Stowell

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NCATS NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Nakahara, H., Cheedarla, N., Verkerke, H. P., Cheedarla, S., Wu, S. C., Hendrickson, J. E., Chang, A., McLemore, M. L., El Rassi, F., Roback, J. D., Neish, A. S., Fasano, R. M., & Stowell, S. R. (2023). Enhanced IgG immune response to COVID ‐19 vaccination in patients with sickle cell disease. British Journal of Haematology. https://doi.org/10.1111/bjh.18899

Vancouver

Nakahara H, Cheedarla N, Verkerke HP, Cheedarla S, Wu SC, Hendrickson JE, et al. Enhanced IgG immune response to COVID ‐19 vaccination in patients with sickle cell disease. British Journal of Haematology. 2023. doi:10.1111/bjh.18899

BibTeX
@article{Nakahara2023,
  author = {Nakahara, Hirotomo and Cheedarla, Narayanaiah and Verkerke, Hans P and Cheedarla, Suneethamma and Wu, Shang-Chuen and Hendrickson, Jeanne E and Chang, Andres and McLemore, Morgan L and El Rassi, Fuad and Roback, John D and Neish, Andrew S and Fasano, Ross M and Stowell, Sean R},
  title = {Enhanced IgG immune response to COVID ‐19 vaccination in patients with sickle cell disease},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.18899}
}
Kostenlos starten →